Effectiveness assessment of autologous adipose tissue derived stromal vascular fraction(SVF) on alopecia

TOP Cell Plastic Surgery0 个研究点目标入组 20 人开始时间: 待定最近更新: 2021年2月23日

适应症

试验速览

暂无简介。

•1. Male and female patients with androgenic alopecia
•2. Age of 20-65 years, provide written informed consent and comply with the study requirements
•3. Norwood-Hamilton grades I-V
•4. Active hair loss within last 12 months
•5. No clinically significant disease or abnormal laboratory results at the time of screening visit
•6. Patient has adequate abdominal or other subcutaneous adipose tissue accessible by syringe-based lipoharvest
•7. For women of child-bearing potential: negative pregnancy test at screening visit

•1. Patients with inflammation, infection, malignancy, allegoric disease, autoimmune disease, pregnancy, diabetes and on current anticoagulant therapy.
•2. Subject who has previously failed or has been deemed nonresponsive to a previous experimental hair loss treatment, prior surgery in the treatment area and subject who has a sensitive, irritated, or abraded scalp area
•3. Clinically significant medical or psychiatric illness currently or within 30 days of study screening as determined by the investigator
•4. Any disease or condition (medical or surgical) that in the opinion of the investigator, might compromise hematologic, cardiovascular, pulmonary, renal, gastrointestinal, hepatic, or central nervous system function; or any condition that would place the subject at increased risk

发起方

TOP Cell Plastic Surgery